EN
HI
Venus Remedies Chart
Venus Remedies Share Key Metrics
Volume
32669.00
Market Cap
2324.65 CR
LTQ@LTP
2@1710.00
ATP
1691.87
Var Margin
100 %
Circuit Range
1652.2-1826
Delivery %
0 %
Value
5.53 CR
ASM/GSM
No
Market Lot
1
Summary
Venus Remedies share price is ₹1710 as of 22 Jun, 2026. The stock Venus Remedies intraday movement has stayed between ₹1666.80 and ₹1775.00, while on a 52-week basis,Venus Remedies price 52 week high is ₹1943.80 & its 52 week low is ₹416.00.
In terms of trading activity, Venus Remedies has recorded a volume of 32669 shares, The Venus Remedies has a market cap of ₹13366988 CR. The stock’s Average Traded Price (ATP) stands at ₹1691.87, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2 @ ₹1710.00.
Venus Remedies operates within a circuit range of ₹1652.20 – ₹1826.00, with a Value of ₹5.53 CR. The Delivery Percentage for the day is 0%. Additionally, Venus Remedies currently falls under the No framework, and trades with a market lot size of 1.
Venus Remedies Fundamentals
P/E Ratio
22.88
P/B Ratio
3.54
Div. Yield
0.57
Sector P/E
69.22
Sector P/B
3.07
Sec. Div. Yield
0.53
Venus Remedies Resistance and Support
Pivot 1744.03
Resistance
First Resistance
1785.06
Second Resistance
1831.03
Third Resistance
1872.06
Support
First Support
1698.06
Second Support
1657.03
Third Support
1611.06
Venus Remedies Corporate Actions
| Date | Agenda |
|---|---|
| 2026-01-29 | Quarterly Results & Others |
| 2025-08-01 | Quarterly Results |
| 2025-07-08 | Others |
Venus Remedies News
Venus Remedies Ltd - 526953 - Venus Remedies Limited Secures Renewal Of Prestigious DSIR In-House R&D Recognition.
Venus Remedies secured the renewal of its in-house Research & Development (R&D) recognition from the Department of Scientific and Industrial Research (DSIR). This renewal confirms VMRC's continued eligibility to conduct critical research in antimicrobial resistance.
Jun 04 2026 16:24:45
Venus Remedies Ltd - 526953 - Adoption Of MOA & AOA As Per The Companies Act 2013
Venus Remedies board approved several key leadership appointments. Mr. Saransh Chaudhary was appointed as Whole Time Director for five years from May 26, 2026. Dr. (Mrs.) Manu Chaudhary was reappointed as Joint Managing Director for five years from October 1, 2026. Both are subject to shareholder approval.
May 26 2026 22:12:45
Read More
Venus Remedies Management
| Name | Position |
|---|---|
| Pawan Chaudhary | Chairman & Managing Director |
| Manu Chaudhary | Joint Managing Director |
Venus Remedies Similar Stocks
Dishman Carbogen Amcis Ltd.
173.36
2.64 (1.55%)
Sai Parenteral's Ltd.
584.25
-8.85 (1.49%)
Kwality Pharmaceuticals Ltd.
2426.70
-58.50 (2.35%)
Hikal Ltd.
206.50
1.73 (0.84%)
Dr Agarwals Eye Hospital Ltd.
5049.00
49.90 (1.00%)
Beta Drugs Ltd.
2170.00
179.80 (9.03%)
Indoco Remedies Ltd.
240.21
5.22 (2.22%)
NGL Fine-Chem Ltd.
3125.10
69.50 (2.27%)
Shalby Ltd.
171.60
0.78 (0.46%)
Sakar Healthcare Ltd.
814.50
10.90 (1.36%)
Venus Remedies FAQs
The Buying Price of Venus Remedies share is 1710 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Venus Remedies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Venus Remedies, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Venus Remedies shares is 22.88. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Venus Remedies shares is 3.54. Useful to assess the stock's value relative to its book value.
To assess Venus Remedies’s valuation compare Sector P/E, P/B which are 69.22 & 3.07 with sector averages, along with growth rates and financial metrics.
The Market Cap of Venus Remedies is 2324.65 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Venus Remedies share price is 1943.80 & 416.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Venus Remedies belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
